Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis.

Wienke, Judith

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis. [electronic resource] - Arthritis & rheumatology (Hoboken, N.J.) 07 2020 - 1214-1226 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2326-5205

10.1002/art.41236 doi


Biomarkers
Chemokine CCL19--immunology
Chemokine CXCL10--immunology
Chemokine CXCL13--immunology
Child
Child, Preschool
Cohort Studies
Dermatomyositis--drug therapy
Duration of Therapy
Endoglin--metabolism
Endothelial Cells--metabolism
Endothelium, Vascular--metabolism
Female
Galectin 1--metabolism
Galectins--metabolism
Humans
Immunosuppressive Agents--therapeutic use
Inflammation--immunology
Intercellular Adhesion Molecule-1--metabolism
Male
Prognosis
Proportional Hazards Models
Receptors, Tumor Necrosis Factor, Type II--immunology